FDA Greenlights First Motion Sickness Drug in More Than 40 Years
(MedPage Today) -- The FDA approved tradipitant (Nereus), an oral neurokinin-1 (NK-1) receptor antagonist, to prevent vomiting induced by motion ...
(MedPage Today) -- The FDA approved tradipitant (Nereus), an oral neurokinin-1 (NK-1) receptor antagonist, to prevent vomiting induced by motion ...
© 2025 PickByDoc. All rights reserved. PickByDoc is a medical news & health awareness platform.